CRISPR Therapeutics Background ... is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

chemistry laureate Jennifer Doudna In her 2020 Nobel Prize lecture, Doudna spoke about all the new opportunities created by the development of the gene-editing tool CRISPR-Cas9. In March last year ...

(2020) found FTase (farnesyltransferase)-dependent cellular factors (a cytokine that acts on RAS proteins) to be associated with sunitinib resistance in clear ... tumors. CRISPR/Cas9 technology ...

An extensive arsenal of biosensing tools has been developed based on the clustered regularly interspaced short palindromic repeat (CRISPR) platform ... approach could enable detection of gene edits ...

Motor neurons (white) and a blood vessel (red), derived from the ALS patient’s stem cells, form functioning tissue, as revealed in this enlarged image (background). Photograph by CRAIG CUTLER ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

When the gene editing tool CRISPR-Cas9 rocketed to fame more than a decade ago, it transformed biotechnology. Faster, cheaper, and safer than previous methods, the tool helped scientists gain insight ...

In the spring, five patients with sickle cell disease began treatment with Casgevy, the first FDA-approved CRISPR-Cas9 gene editing treatment. The therapy—which involves removing blood stem ...

The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...